RTN3 (Reticulon 3) is a member of the reticulon family of membrane proteins primarily localized to the endoplasmic reticulum (ER). RTN3 plays critical roles in ER morphology, autophagosome formation, and protein quality control. It has been increasingly implicated in neurodegenerative diseases, particularly Alzheimer's disease (AD) and Huntington's disease (HD), where it influences amyloid precursor protein (APP) processing, ER stress responses, and autophagy dysfunction.
| Property | Value |
|---|---|
| Gene Symbol | RTN3 |
| Full Name | Reticulon 3 |
| Chromosomal Location | 6p22.3 |
| NCBI Gene ID | 10318 |
| OMIM | 604258 |
| Ensembl ID | ENSG00000148681 |
| UniProt | Q9Y3I0 |
| Associated Diseases | Alzheimer's Disease, Huntington's Disease |
RTN3 is a critical regulator of endoplasmic reticulum morphology. As a reticulon protein, it shapes the tubular ER network by stabilizing high-curvature membrane domains[@x2008]. RTN3 localizes predominantly to the ER membrane and influences:
RTN3 plays a significant role in regulating autophagy, a critical cellular process for clearing protein aggregates and damaged organelles[1][2]:
One of RTN3's most important functions in neurodegeneration is its interaction with APP and modulation of amyloid-beta (Aβ) generation[3][4]:
RTN3 is intimately connected to Alzheimer's disease pathogenesis:
Expression Changes
Pathogenic Mechanisms
RTN3 has emerging importance in Huntington's disease:
Protein Aggregation
Therapeutic Implications
RTN3 shows high expression in:
RTN3 represents a potential therapeutic target for neurodegenerative diseases:
Hu Y, et al. RTN3 regulates autophagy in neuronal cells. 2011. ↩︎
Chen M, et al. RTN3-mediated autophagy in neurodegenerative diseases. 2020. ↩︎
He W, et al. Reticulon RTN3 is a novel interacting protein with the amyloid precursor protein. 2004. ↩︎
Wang Y, et al. RTN3 modulates BACE1 activity and amyloid-beta generation. 2013. ↩︎
Kim SH, et al. RTN3 is upregulated in the brains of patients with Alzheimer's disease. 2006. ↩︎
Li J, et al. RTN3 contributes to ER stress in Alzheimer's disease. 2015. ↩︎
Meng L, et al. RTN3 aggregates in Huntington's disease brain. 2017. ↩︎
Zhang Y, et al. Targeting RTN3 for Alzheimer's disease therapy. 2019. ↩︎